Oxidation of LDL and extent of peripheral atherosclerosis

References

• Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol; modifications of low-density lipoprotein that increase its atherogenicity. New England Journal of Medicine 1989; 320: 915–923
   PubMed Web of Science ®Google Scholar
• Witztum J.L., Steinberg D. Role of oxidative modification of LDL in atherogenesis. Journal of Clinical Investigations 1991; 88: 1785–1792
   PubMed Web of Science ®Google Scholar
• Halliwell B. How to characterize a biological antioxidant (Review). Free Radical Research Communications 1990; 9: 1–32
   PubMed Web of Science ®Google Scholar
• Holvoet P., Perez G., Zhao Z., Brouwers E., Bernar H., Collen D. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. Journal of Clinical Investigations 1995; 95: 2611–2619
   PubMed Web of Science ®Google Scholar
• Palinski W., Horkko S., Miller E., Steinbrecher U.P., Powell H.C., Curtiss L.K., Witztum J.L. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice — Demonstration of epitopes of oxidized low density lipoprotein in human plasma. Journal of Clinical Investigations 1996; 98: 800–814
   PubMed Web of Science ®Google Scholar
• Ylä-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. Journal of Clinical Investigations 1989; 84: 1086–1095
   PubMed Web of Science ®Google Scholar
• Palinski W., Rosenfeld M.E., Ylä-Herttuala S., Gurtner G.C., Socher S.A., Butler S.W., Parthasarathy S., Carew T.E., Steinberg D., Witztum J.L. Low density lipoprotein undergoes oxidative modification in vivo. Proceedings of the National Academy of Science, USA 1989; 86: 1372–1376
   PubMed Web of Science ®Google Scholar
• van de Vijver L.P.L., Steyger R., van Poppel G., Boer J.M.A., Kruijssen D.A.C.M., Seidell J.C., Princen H.M.G. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls. Atherosclerosis 1996; 122: 245–253
   PubMed Web of Science ®Google Scholar
• Princen H.M.G., van Poppel G., Vogelezang C., Buytenhek R., Kok F.J. Supplementation with vitamin E but not β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking. Arteriosclerosis and Thrombosis 1992; 12: 554–562
   PubMed Web of Science ®Google Scholar
• Reaven P., Khouw A., Beltz W.F., Parthasarathy S., Witztum J.L. Effect of dietary antioxidant combination in humans; protection of LDL by vitamin E but not by β-carotene. Arteriosclerosis and Thrombosis 1993; 13: 590–600
   PubMed Web of Science ®Google Scholar
• Princen H.M.G., van Duyvenvoorde W., Buytenhek R., van der Laarse A., vanPoppel G., Gevers Leuven J.A., van Hinsbergh V.W.M. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arteriosclerosis, Thrombosis and Vascular Biology 1995; 15: 325–333
   PubMed Web of Science ®Google Scholar
• Berry E.M., Eisenberg S., Haratz D., Friedlander Y., Norman Y., Kaufmann N.A., Stein Y. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins — the Jerusalem Nutrition Study: high MUFAs vs high PUFAs. American Journal of Clinical Nutrition 1991; 53: 899–907
   PubMed Web of Science ®Google Scholar
• Reaven P.D., Grasse B.J., Tribble D.L. Effects of linoleate-enriched and oleate-enriched diets in combination with α-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arteriosclerosis and Thrombosis 1994; 14: 557–566
   PubMed Web of Science ®Google Scholar
• Hau M-F., Smelt A.H.M., Bindels A.J.G.H., Sijbrands E.J.G., van derLaarse A., Onkenhout W., van Duyvenvoorde W., Princen H.M.G. Effects of fish oil on oxidation resistance of very low density lipoprotein in hypertriglyceridemic patients. Arteriosclerosis, Thrombosis and Vascular Biology 1996; 16: 1197–1202
   PubMed Web of Science ®Google Scholar
• Bellizzi M.C., Franklin M.F., Duthy G.G., James W.P.T. Vitamin E and coronary heart disease: the European paradox. European Journal of Clinical Nutrition 1994; 48: 822–831
   PubMed Web of Science ®Google Scholar
• Enstrom J.E., Kanim L.E., Klein M.A. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992; 3: 194–202
   PubMed Web of Science ®Google Scholar
• Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. New England Journal of Medicine 1993; 328: 1450–1456
   PubMed Web of Science ®Google Scholar
• Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary disease in women. New England Journal of Medicine 1993; 328: 1444–1449
   PubMed Web of Science ®Google Scholar
• Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Research Communication 1989; 6: 67–75
   PubMed Web of Science ®Google Scholar
• Regnström J., Nilsson J., Tornvall P., Landou C., Hamsten A. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992; 339: 1183–1186
   PubMed Web of Science ®Google Scholar
• Cominacini L., Garbin U., Pastorini A.M., Davoli A., Campagnola M., de Santis A., Pasini C., Faccini G.B., Trevisan M.T., Bertozzo L., Pasini F., Lo Cascio V. Predisposition to LDL Oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis 1993; 99: 63–70
   PubMed Web of Science ®Google Scholar
• de Rijke Y.B., Verwey H.F., Vogelezang C.J.M., van derVelde E.A., Princen H.M.G., van der Laarse A., Bruschke A.V.G., van Berkel T.J.C. Enhanced susceptibility of low-density lipoproteins to oxidation in coronary bypass patients with progression of atherosclerosis. Clinical Chimica Acta 1995; 243: 137–149
   PubMed Web of Science ®Google Scholar
• van de Vijver L.P.L., Kardinaal A.F.M., van Duyvenvoorde W., Kruyssen D.A.C.M., Grobbee D.E., van Poppel G., Princen H.M.G. LDL oxidation and extent of coronary atherosclerosis. Arteriosclerosis, Thrombosis and Vascular Biology 1998; 18: 193–199
   PubMed Web of Science ®Google Scholar
• Ziedén B., Mölgaard J., Ziedén A.G. Olsson. Low-density lipoprotein oxidation and coronary atherosclerosis (letter to the editor). Lancet 1992; 340: 727–728
   PubMed Web of Science ®Google Scholar
• Ziedén B., Mölgaard J., Olsson A.G. Copper-induced low density lipoprotein oxidation is not a risk discriminator for intermittent claudication. VASA: Zeitschrift für Gefässkrankheiten 1996; 25: 121–126
   PubMedGoogle Scholar
• Stringer M.D., Görög P.G., Freeman A., Kakkar V.V. Lipid peroxides and atherosclerosis. British Medical Journal 1989; 298: 281–284
   PubMed Web of Science ®Google Scholar
• Sanderson K.J., van Rij A.M., Wade C.R., Sutherland W.H.F. Lipid peroxidation of circulating low density lipoproteins with age, smoking and in peripheral vascular disease. Atherosclerosis 1995; 118: 45–51
   PubMed Web of Science ®Google Scholar
• Bergmark C., Wu R., De Faire U., Lefvert A.K., Swedenborg J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arteriosclerosis, Thrombosis and Vascular Biology 1995; 15: 441–445
   PubMed Web of Science ®Google Scholar
• Hofman A., Grobbee D.E., de Jong P.T.V.M., van den Ouweland F.A. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. European Journal of Epidemiology 1991; 7: 403–422
   PubMed Web of Science ®Google Scholar
• Princen H.M.G., van Duyvenvoorde W., Buytenhek R., Blonk C., Tijburg L.B.M., Langius J.A.E., Meinders A.E., Pijl H. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arteriosclerosis, Thrombosis and Vascular Biology 1998; 18: 833–841
   PubMed Web of Science ®Google Scholar
• Brussaard H.E., Gevers Leuven J.A., Kluft C., Krans H.M.J., van Duyvenvoorde W., Buytenhek R., van der Laarse A., Princen H.M.G. Effect of 17β-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type 2 diabetes mellitus. Arteriosclosis, Thrombosis and Vascular Biology 1997; 17: 324–330
   PubMed Web of Science ®Google Scholar
• Scheek L.M., Wiseman S.A., Tijburg L.B.M., van Tol A. Dialysis of isolated low density lipoprotein induces a loss of lipophilic antioxidants and increases susceptibility to oxidation in vitro. Atherosclerosis 1995; 117: 139–144
   PubMed Web of Science ®Google Scholar
• Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Lopes-Virella M.F., Stone P., Ellis S., Colwell J.A. Cholesterol determination in high density lipoproteins separated by three different methods. Clinical Chemistry 1977; 23: 882–884
   PubMed Web of Science ®Google Scholar
• Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation. Clinical Chemistry 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• van Vliet T., van Schaik F., van Schoonhoven J., Schrijver J. Determination of several retinoids, carotenoids and E vitamers by high-performance liquid chromatography application to plasma and tissues of rats fed a diet rich in either β-carotene or canthaxanthin. Journal of Chromatology 1991; 553: 179–186
   PubMed Web of Science ®Google Scholar
• BMDP Statistical software manual, W.J. Dixon, California 1992, version 7.0
   Google Scholar
• Vogt M.T., Wolfson S.K., Kuller L.H. Segmental arterial disease in the lower extremities: correlates of disease and relationship to mortality. Journal of Clinical Epidemiology 1993; 46: 1267–1276
   PubMed Web of Science ®Google Scholar
• Bots M.L., Hofman A., Grobbee D.E. Common carotid intima-media thickness and lower extremity arterial atherosclerosis; the Rotterdam Study. Arteriosclerosis and Thrombosis 1994; 14: 1885–1891
   PubMedGoogle Scholar
• Schroll M., Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. 1981
   Google Scholar
• Journal of Chronic Diseases, 34: 261–269
   PubMedGoogle Scholar
• Fowkes F.G.R., Housley B., Cawood E.H.H., Macintyre C.A., Ruckley C.V., Prescott R.J. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral artherial disease in the general population. International Journal of Epidemiology 1991; 20: 384–392
   PubMed Web of Science ®Google Scholar
• de Graaf J., Hak-Lemmers H.L.M., Hectors M.P.C., Demacker P.N.M., Hendriks J.C.M., Stalenhoef A.F.H. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arteriosclerosis and Thrombosis 1991; 11: 298–306
   PubMed Web of Science ®Google Scholar
• Tribble D.L., Holl L.G., Wood P.D., Krauss R.M. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 1992; 93: 189–199
   PubMed Web of Science ®Google Scholar
• Croft K.D., Dimmitt S.B., Moulton C., Beilin L.J. Low density lipoprotein composition and oxidizability in coronary disease-apparent favourable effect of beta blockers. Atherosclerosis 1992; 97: 123–130
   PubMed Web of Science ®Google Scholar
• Godfrey E.G., Stewart J., Dargie H.J., Reid J., Hamilton M., McMurray J. Effects of ACE inhibitors on oxidation of human low density lipoprotein. British Journal of Clinical Pharmacology 1994; 37: 63–66
   PubMed Web of Science ®Google Scholar
• Hoffman R., Brook G.J., Aviram M. Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies. Atherosclerosis 1992; 93: 105–113
   PubMed Web of Science ®Google Scholar
• Liu K., Cuddy E., Pierce G.N. Oxidative status of lipoproteins in coronary disease patients. American Heart Journal 1992; 123: 285–290
   PubMed Web of Science ®Google Scholar
• Wilt T.J., Bloomfield Rubins H., Collins D., O'Conner T.Z., Rutan G.H., Robins S.J. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Archives of Internal Medicine 1996; 156: 1181–1188
   PubMedGoogle Scholar
• Chirico S., Smith C., Marchant C., Mitchinson M.J., Halliwell B. Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobabituric acid test. Free Radical Research Communication 1993; 19: 51–57
   PubMed Web of Science ®Google Scholar